BRM invests in early stage and growth startups, backing companies across their scale up journey.

BRM invests across multiple stages and sectors, led by dedicated partners: early-stage technology investments led by Eran Barkat; early-stage life sciences investments led by Alon Maor and growth-stage technology investments led by Timor Arbel-Sadras.

We often lead or co-lead rounds, although it is not a requirement for us to move forward.

We operate with flexible and independent decision-making, with direct ownership by the relevant partner. Our diligence is tailored to the company and stage, and we move fast when needed-without compromising judgment or depth.

Yes. We have the flexibility and capital to support companies from Seed through IPO and have done so repeatedly with high-performing companies.

BRM is funded by its own ongoing successes and is not tied to a fixed fund size or lifetime, allowing us to support companies based on opportunity and performance.

It means a company-first partnership. Decisions are made based on what is right for the company and founders-especially around capital structure decisions, market or business model transitions, and liquidity considerations.

Through decades of investment and operating experience, we bring strategic, financial, and business judgment that adds balance in boardrooms and unconventional problem-solving in complex situations.

We believe in promoting the Israeli entrepreneur regardless of the location of activity. Accordingly, we require that at least one of the founding members be Israeli.

We work best through trusted relationships. The fastest path is a warm intro via a portfolio founder/exec or a co-investor we know.